State of Tennessee, Department of Treasury’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$855K Sell
94,922
-1,043
-1% -$16.5K ﹤0.01% 1265
2025
Q4
$1.66M Sell
95,965
-9,899
-9% -$167K 0.01% 1008
2025
Q3
$1.55M Buy
105,864
+1,800
+2% +$30.9K 0.01% 1020
2025
Q2
$1.9M Sell
104,064
-866
-0.8% -$17.7K 0.01% 913
2025
Q1
$2.08M Sell
104,930
-552
-0.5% -$9.55K 0.01% 859
2024
Q4
$1.81M Buy
105,482
+21,367
+25% +$402K 0.01% 958
2024
Q3
$1.68M Buy
+84,115
New +$1.31M 0.01% 990

Other funds holding ADMA

State of Tennessee, Department of Treasury's ADMA Position: Q1 2026 in Review

State of Tennessee, Department of Treasury reduced its ADMA Biologics (ADMA) stake by 1.1% in Q1 2026, selling an estimated $16.5K and leaving 94,922 shares worth $855K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

State of Tennessee, Department of Treasury first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.08M in Q1 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • State of Tennessee, Department of Treasury held 94,922 shares of ADMA Biologics worth $855K as of Q1 2026.
  • State of Tennessee, Department of Treasury sold 1,043 ADMA Biologics shares in Q1 2026, an estimated $16.5K.
  • ADMA Biologics made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1265 holding.
  • State of Tennessee, Department of Treasury first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • State of Tennessee, Department of Treasury's ADMA Biologics position peaked at $2.08M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.